Research Paper (22)

  • Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.
    Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.

    Elena-Diana Chiru

    Get Access
  • Artificial Intelligence in Cancer Medicine: The Future of Cancer Care?
    Artificial Intelligence in Cancer Medicine: The Future of Cancer Care?

    Marcus Vetter

    Get Access
  • Emberger Syndrome – A Family History Over 3 Generations
    Emberger Syndrome – A Family History Over 3 Generations

    Laura Rüegsegger

    Get Access
  • Highlights in Prostate Cancer from ASCO GU 2022
    Highlights in Prostate Cancer from ASCO GU 2022

    Alexander Meisel

    Get Access
  • Artificial Intelligence Clinical Application in Prostate Cancer Molecular Imaging
    Artificial Intelligence Clinical Application in Prostate Cancer Molecular Imaging

    Riccardo Laudicella

    Get Access
  • ESMO Updates the Guidelines for the Diagnosis of *RET*-Altered Cancer to Herald a New Era in Targeted Therapy
    ESMO Updates the Guidelines for the Diagnosis of *RET*-Altered Cancer to Herald a New Era in Targeted Therapy

    Alfredo Addeo

    Get Access
  • Breast Cancer Treatment in the Era of Precision Medicine
    Breast Cancer Treatment in the Era of Precision Medicine

    Marcus Vetter

    Get Access
  • Response to Osimertinib in a Patient with Non-Small Cell Lung Cancer and Two Uncommon EGFR Mutations
    Response to Osimertinib in a Patient with Non-Small Cell Lung Cancer and Two Uncommon EGFR Mutations

    Christoforos Astaras

    Get Access
  • Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations
    Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations

    David König

    Get Access
  • Avenues to Precision Oncology
    Avenues to Precision Oncology

    Alexander Meisel

    Get Access
  • A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line
    A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line

    Sara De Dosso

    Get Access
  • A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line
    A Rational Sequencing of Anti-Angiogenic Agents as Second-Line Treatment Choice for mCRC Patients Progressing After a Bevacizumab-Based First Line

    Sara De Dosso

    Get Access
  • Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
    Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin

    Adrian Schmidt

    Get Access
  • CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement
    CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement

    Antonia Maria S. Müller

    Get Access
  • Therapy Management of Metastatic Prostate Carcinoma in General Practice
    Therapy Management of Metastatic Prostate Carcinoma in General Practice

    Alexander Meisel

    Get Access
  • Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?
    Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

    Alexander Meisel

    Get Access
  • CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement
    CD19-Directed CAR T Cells Treatment in a Patient with Refractory DLBCL and CNS Involvement

    Antonia Maria S. Müller

    Get Access
  • The CAR T Cell Story
    The CAR T Cell Story

    Norman Russkamp

    Get Access
  • PSMA-Directed Radioligand Therapy for Metastatic Prostate Cancer
    PSMA-Directed Radioligand Therapy for Metastatic Prostate Cancer

    Ellen Heitlinger

    Get Access
  • Updates on Radiotherapy for Localized Prostate Cancer
    Updates on Radiotherapy for Localized Prostate Cancer

    Alexandros Papachristofilou

    Get Access
  • Current Advances in the Perioperative Treatment of Muscle-Invasive Bladder Cancer
    Current Advances in the Perioperative Treatment of Muscle-Invasive Bladder Cancer

    Ursula Vogl

    Get Access
  • Effect of Acalabrutinib in Combination with Bendamustine plus Rituximab on Survival Endpoints in Older Patients with Mantle Cell Lymphoma: Insights from the ECHO Trial
    Effect of Acalabrutinib in Combination with Bendamustine plus Rituximab on Survival Endpoints in Older Patients with Mantle Cell Lymphoma: Insights from the ECHO Trial

    Adrian Schmidt

    Get Access

Your Feedback